Chenkai Wu1, Ellen Smit1, Jason L Sanders2, Anne B Newman3, Michelle C Odden1. 1. School of Biological and Population Health Sciences, Oregon State University, Corvallis. 2. Department of Medicine, Massachusetts General Hospital, Boston. 3. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Comorbidity indices that are based on clinically recognized disease do not capture the full spectrum of health. The Healthy Aging Index (HAI) was recently developed to describe a wider range of health and disease across multiple organ systems. We characterized the distribution of a modified HAI (mHAI) by sociodemographics in a representative sample of the U.S. population. We also examined the association of the mHAI with mortality across individuals with different levels of clinically recognizable comorbidities. METHODS: Data are from the National Health and Nutrition Examination Survey (1999-2000, 2001-2002) on 2,451 adults aged 60 years or older. Five mHAI components (systolic blood pressure, Digit Symbol Substitution Test, cystatin C, glucose, and respiratory problems) were scored 0 (healthiest), 1, or 2 (unhealthiest) by sex-specific tertiles or clinically relevant cutoffs and summed to construct the mHAI. RESULTS: The mean mHAI score was 4.3; 20.6% had a score of 0-2. 33.2% had a score of 3-4, 31.0% had a score of 5-6, and 15.2% had a score of 7-10. Mean mHAI scores were lower in adults who were younger, non-Hispanic whites, more educated, and married/living with partner. After multivariate adjustment, per unit higher of the mHAI was associated with higher all-cause mortality (HR = 1.19, 95% CI = 1.11-1.27) and higher cardiovascular mortality (HR = 1.23, 95% CI = 1.11-1.35). Within each comorbidity category (0, 1, 2, 3, 4+), the mHAI was still widely distributed and further stratified mortality. CONCLUSIONS: Substantial variation exists in the mHAI across sociodemographic subgroups. The mHAI could provide incremental value for mortality risk prediction beyond clinically diagnosed chronic diseases among elders.
BACKGROUND: Comorbidity indices that are based on clinically recognized disease do not capture the full spectrum of health. The Healthy Aging Index (HAI) was recently developed to describe a wider range of health and disease across multiple organ systems. We characterized the distribution of a modified HAI (mHAI) by sociodemographics in a representative sample of the U.S. population. We also examined the association of the mHAI with mortality across individuals with different levels of clinically recognizable comorbidities. METHODS: Data are from the National Health and Nutrition Examination Survey (1999-2000, 2001-2002) on 2,451 adults aged 60 years or older. Five mHAI components (systolic blood pressure, Digit Symbol Substitution Test, cystatin C, glucose, and respiratory problems) were scored 0 (healthiest), 1, or 2 (unhealthiest) by sex-specific tertiles or clinically relevant cutoffs and summed to construct the mHAI. RESULTS: The mean mHAI score was 4.3; 20.6% had a score of 0-2. 33.2% had a score of 3-4, 31.0% had a score of 5-6, and 15.2% had a score of 7-10. Mean mHAI scores were lower in adults who were younger, non-Hispanic whites, more educated, and married/living with partner. After multivariate adjustment, per unit higher of the mHAI was associated with higher all-cause mortality (HR = 1.19, 95% CI = 1.11-1.27) and higher cardiovascular mortality (HR = 1.23, 95% CI = 1.11-1.35). Within each comorbidity category (0, 1, 2, 3, 4+), the mHAI was still widely distributed and further stratified mortality. CONCLUSIONS: Substantial variation exists in the mHAI across sociodemographic subgroups. The mHAI could provide incremental value for mortality risk prediction beyond clinically diagnosed chronic diseases among elders.
Authors: W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried Journal: Stroke Date: 1996-08 Impact factor: 7.914
Authors: Bradley J Willcox; Qimei He; Randi Chen; Katsuhiko Yano; Kamal H Masaki; John S Grove; Timothy A Donlon; D Craig Willcox; J David Curb Journal: JAMA Date: 2006-11-15 Impact factor: 56.272
Authors: B M Psaty; C D Furberg; L H Kuller; M Cushman; P J Savage; D Levine; D H O'Leary; R N Bryan; M Anderson; T Lumley Journal: Arch Intern Med Date: 2001-05-14
Authors: Elizabeth L M Barr; Paul Z Zimmet; Timothy A Welborn; Damien Jolley; Dianna J Magliano; David W Dunstan; Adrian J Cameron; Terry Dwyer; Hugh R Taylor; Andrew M Tonkin; Tien Y Wong; John McNeil; Jonathan E Shaw Journal: Circulation Date: 2007-06-18 Impact factor: 29.690
Authors: Elizabeth L McCabe; Martin G Larson; Kathryn L Lunetta; Anne B Newman; Susan Cheng; Joanne M Murabito Journal: J Gerontol A Biol Sci Med Sci Date: 2016-04-26 Impact factor: 6.053
Authors: Anne B Newman; Robert M Boudreau; Barbara L Naydeck; Linda F Fried; Tamara B Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2008-06 Impact factor: 6.053
Authors: Matthew D L O'Connell; Megan M Marron; Robert M Boudreau; Mark Canney; Jason L Sanders; Rose Anne Kenny; Stephen B Kritchevsky; Tamara B Harris; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2019-04-23 Impact factor: 6.053
Authors: Lauren N Shaver; Daniel P Beavers; Jessica Kiel; Stephen B Kritchevsky; Kristen M Beavers Journal: J Gerontol A Biol Sci Med Sci Date: 2019-07-12 Impact factor: 6.053
Authors: Javier de la Fuente; Francisco Félix Caballero; Albert Sánchez-Niubó; Demosthenes B Panagiotakos; A Matthew Prina; Holger Arndt; Josep Maria Haro; Somnath Chatterji; José Luis Ayuso-Mateos Journal: J Gerontol A Biol Sci Med Sci Date: 2018-10-08 Impact factor: 6.053
Authors: Chenkai Wu; Kehan Zhang; Michelle C Odden; Anna M Kucharska-Newton; Priya Palta; Kunihiro Matsushita; Rebecca F Gottesman; B Gwen Windham Journal: J Gen Intern Med Date: 2021-01-19 Impact factor: 6.473
Authors: Polina Mamoshina; Lucy Ojomoko; Yury Yanovich; Alex Ostrovski; Alex Botezatu; Pavel Prikhodko; Eugene Izumchenko; Alexander Aliper; Konstantin Romantsov; Alexander Zhebrak; Iraneus Obioma Ogu; Alex Zhavoronkov Journal: Oncotarget Date: 2017-11-09
Authors: Chenkai Wu; Ya-Xi Li; Megan M Marron; Michelle C Odden; Anne B Newman; Jason L Sanders Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-25 Impact factor: 6.591